Detailed Description for Methodology
A) Herbal medicines and plant extracts. As a first part of the study, we used Calophyllum brasiliense since it contains several active compounds such as coumarins and xanthones and they may represent new alternatives for the treatment of different diseases.
B) Isolated compounds.
In the present study, we only focused on mammea A/BA and A/BB. C) Targets fishing: Network pharmacology methodologies are mainly based on the multiple-target pharmacology capabilities of the molecules, which possess similar properties to a social network but are based on drug-target interactions (particularly with proteins). There are several open-access databases where knowledge of protein-target interaction binding data is available, such as STITCH, DRAR-CPI, SwissTarget, and Comparative Toxicogenomics Database (CTD), where the simple knowledge of the molecular structure is enough to obtain a series of ligands ranked from more probable to less probable interactions according to the structure. For a detailed explanation of methodologies, please refer to Boezio B et al., 2017 .
D) Enrichment analysis:
Once that we obtain the potential targets from databases, enrichment analysis of significant pathways was performed with the CTD Database and the Gene Set Enrichment Analysis in Python (GSEAPY) both include computational methods that determine whether an a priori defined set of genes, shows statistically significate values for different pathways or genes. For a detailed explanation of methodologies please refer to Khatri et al., 2012. E) Network construction: Network were constructed with Cytoscape v3.5 by using GeneMania plugin data and connecting the candidate targets with several functional associations, such as physical interactions, shared common signaling pathways, and predicted physical interactions.
F) Experimental validation:
The new potential targets and pathways should be validated, since several network pharmacological approaches are theoretical. 
